Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 24 entries
Sorted by: Best Match Show Resources per page
MR imaging findings of a patient with isolated intrahepatic splenosis mistaken for hepatocellular carcinoma.

BJR case reports

Somsap K, Chamadol N, Titapun A, Pairojkul C, Sangkhamanon S.
PMID: 30363334
BJR Case Rep. 2016 Sep 29;3(1):20150242. doi: 10.1259/bjrcr.20150242. eCollection 2017.

Splenosis refers to the autotransplantation of splenic tissue throughout different anatomic compartments secondary to trauma or splenic surgery. The liver is an uncommon location for splenic implants and imaging findings are often described as non-specific. We report MRI findings...

Cite
Somsap K, Chamadol N, Titapun A, et al. MR imaging findings of a patient with isolated intrahepatic splenosis mistaken for hepatocellular carcinoma. BJR Case Rep. 2016;3(1):20150242doi: 10.1259/bjrcr.20150242.
Somsap, K., Chamadol, N., Titapun, A., Pairojkul, C., & Sangkhamanon, S. (2017). MR imaging findings of a patient with isolated intrahepatic splenosis mistaken for hepatocellular carcinoma. BJR case reports, 3(1), 20150242. https://doi.org/10.1259/bjrcr.20150242
Somsap, Kulyada, et al. "MR imaging findings of a patient with isolated intrahepatic splenosis mistaken for hepatocellular carcinoma." BJR case reports vol. 3,1 (2017): 20150242. doi: https://doi.org/10.1259/bjrcr.20150242
Somsap K, Chamadol N, Titapun A, Pairojkul C, Sangkhamanon S. MR imaging findings of a patient with isolated intrahepatic splenosis mistaken for hepatocellular carcinoma. BJR Case Rep. 2016 Sep 29;3(1):20150242. doi: 10.1259/bjrcr.20150242. eCollection 2017. PMID: 30363334; PMCID: PMC6159292.
Copy Download .nbib Format: NLM
Genetic and epigenetic alterations of RIZ1 and the correlation to clinicopathological parameters in liver fluke-related cholangiocarcinoma.

Experimental and therapeutic medicine

Khaenam P, Jearanaikoon P, Pairojkul C, Bhudhisawasdi V, Limpaiboon T.
PMID: 22993552
Exp Ther Med. 2010 Mar;1(2):385-390. doi: 10.3892/etm_00000060. Epub 2010 Mar 01.

The retinoblastoma interacting zinc finger (RIZ1) gene is adjacent to D1S228 where microsatellite instability has been associated with poor patient survival in liver fluke-associated cholangiocarcinoma (CCA). An understanding of the molecular mechanisms underlying the carcinogenesis and pathogenesis of CCA...

Cite
Khaenam P, Jearanaikoon P, Pairojkul C, et al. Genetic and epigenetic alterations of RIZ1 and the correlation to clinicopathological parameters in liver fluke-related cholangiocarcinoma. Exp Ther Med. 2010;1(2):385-390doi: 10.3892/etm_00000060.
Khaenam, P., Jearanaikoon, P., Pairojkul, C., Bhudhisawasdi, V., & Limpaiboon, T. (2010). Genetic and epigenetic alterations of RIZ1 and the correlation to clinicopathological parameters in liver fluke-related cholangiocarcinoma. Experimental and therapeutic medicine, 1(2), 385-390. https://doi.org/10.3892/etm_00000060
Khaenam, Prasong, et al. "Genetic and epigenetic alterations of RIZ1 and the correlation to clinicopathological parameters in liver fluke-related cholangiocarcinoma." Experimental and therapeutic medicine vol. 1,2 (2010): 385-390. doi: https://doi.org/10.3892/etm_00000060
Khaenam P, Jearanaikoon P, Pairojkul C, Bhudhisawasdi V, Limpaiboon T. Genetic and epigenetic alterations of RIZ1 and the correlation to clinicopathological parameters in liver fluke-related cholangiocarcinoma. Exp Ther Med. 2010 Mar;1(2):385-390. doi: 10.3892/etm_00000060. Epub 2010 Mar 01. PMID: 22993552; PMCID: PMC3445879.
Copy Download .nbib Format: NLM
Adaptor protein XB130 regulates the aggressiveness of cholangiocarcinoma.

PloS one

Poosekeaw P, Pairojkul C, Sripa B, Sa Ngiamwibool P, Iamsaard S, Sakonsinsiri C, Thanan R, Ungarreevittaya P.
PMID: 34780466
PLoS One. 2021 Nov 15;16(11):e0259075. doi: 10.1371/journal.pone.0259075. eCollection 2021.

Cholangiocarcinoma (CCA) is a group of heterogenous malignancies arising from bile duct epithelium with distinct pathological features. Adaptor proteins have implicated in cell proliferation, migration, and invasion of different cancer cells. The objective of this study was to assess...

Cite
Poosekeaw P, Pairojkul C, Sripa B, et al. Adaptor protein XB130 regulates the aggressiveness of cholangiocarcinoma. PLoS One. 2021;16(11):e0259075doi: 10.1371/journal.pone.0259075.
Poosekeaw, P., Pairojkul, C., Sripa, B., Sa Ngiamwibool, P., Iamsaard, S., Sakonsinsiri, C., Thanan, R., & Ungarreevittaya, P. (2021). Adaptor protein XB130 regulates the aggressiveness of cholangiocarcinoma. PloS one, 16(11), e0259075. https://doi.org/10.1371/journal.pone.0259075
Poosekeaw, Pirawan, et al. "Adaptor protein XB130 regulates the aggressiveness of cholangiocarcinoma." PloS one vol. 16,11 (2021): e0259075. doi: https://doi.org/10.1371/journal.pone.0259075
Poosekeaw P, Pairojkul C, Sripa B, Sa Ngiamwibool P, Iamsaard S, Sakonsinsiri C, Thanan R, Ungarreevittaya P. Adaptor protein XB130 regulates the aggressiveness of cholangiocarcinoma. PLoS One. 2021 Nov 15;16(11):e0259075. doi: 10.1371/journal.pone.0259075. eCollection 2021. PMID: 34780466; PMCID: PMC8592414.
Copy Download .nbib Format: NLM
Integration of Specialist Palliative Care into Tertiary Hospitals: A Multicenter Point Prevalence Survey from Thailand.

Palliative medicine reports

Pairojkul S, Thongkhamcharoen R, Raksasataya A, Sorasit C, Nakawiro P, Sudsa S, Sattamai C, Puripanpinyo N, Oerareemitr N, Raksadaen B, Apaijitt P, Santisant B, Thammachote P, Thunyawan S, Rattanachun V, Fagcharoenpol V.
PMID: 34927153
Palliat Med Rep. 2021 Oct 06;2(1):272-279. doi: 10.1089/pmr.2021.0003. eCollection 2021.

No abstract available.

Cite
Pairojkul S, Thongkhamcharoen R, Raksasataya A, et al. Integration of Specialist Palliative Care into Tertiary Hospitals: A Multicenter Point Prevalence Survey from Thailand. Palliat Med Rep. 2021;2(1):272-279doi: 10.1089/pmr.2021.0003.
Pairojkul, S., Thongkhamcharoen, R., Raksasataya, A., Sorasit, C., Nakawiro, P., Sudsa, S., Sattamai, C., Puripanpinyo, N., Oerareemitr, N., Raksadaen, B., Apaijitt, P., Santisant, B., Thammachote, P., Thunyawan, S., Rattanachun, V., & Fagcharoenpol, V. (2021). Integration of Specialist Palliative Care into Tertiary Hospitals: A Multicenter Point Prevalence Survey from Thailand. Palliative medicine reports, 2(1), 272-279. https://doi.org/10.1089/pmr.2021.0003
Pairojkul, Srivieng, et al. "Integration of Specialist Palliative Care into Tertiary Hospitals: A Multicenter Point Prevalence Survey from Thailand." Palliative medicine reports vol. 2,1 (2021): 272-279. doi: https://doi.org/10.1089/pmr.2021.0003
Pairojkul S, Thongkhamcharoen R, Raksasataya A, Sorasit C, Nakawiro P, Sudsa S, Sattamai C, Puripanpinyo N, Oerareemitr N, Raksadaen B, Apaijitt P, Santisant B, Thammachote P, Thunyawan S, Rattanachun V, Fagcharoenpol V. Integration of Specialist Palliative Care into Tertiary Hospitals: A Multicenter Point Prevalence Survey from Thailand. Palliat Med Rep. 2021 Oct 06;2(1):272-279. doi: 10.1089/pmr.2021.0003. eCollection 2021. PMID: 34927153; PMCID: PMC8675094.
Copy Download .nbib Format: NLM
Mucin-producing hamster cholangiocarcinoma cell line, Ham-2, possesses the aggressive cancer phenotypes with liver and lung metastases.

In vitro cellular & developmental biology. Animal

Boonnate P, Vaeteewoottacharn K, Kariya R, Fujikawa S, Boonmars T, Pinlaor S, Pairojkul C, Okada S.
PMID: 34549357
In Vitro Cell Dev Biol Anim. 2021 Sep;57(8):825-834. doi: 10.1007/s11626-021-00608-z. Epub 2021 Sep 21.

Cholangiocarcinoma (CCA) is an aggressive bile duct cancer. Opisthorchis viverrini (O. viverrini) infection is a significant cause of CCA in the Greater Mekong subregion. Currently, there is no standard chemotherapeutic regimen for CCA. A unique hamster carcinogenesis model of...

Cite
Boonnate P, Vaeteewoottacharn K, Kariya R, et al. Mucin-producing hamster cholangiocarcinoma cell line, Ham-2, possesses the aggressive cancer phenotypes with liver and lung metastases. In Vitro Cell Dev Biol Anim. 2021;57(8):825-834doi: 10.1007/s11626-021-00608-z.
Boonnate, P., Vaeteewoottacharn, K., Kariya, R., Fujikawa, S., Boonmars, T., Pinlaor, S., Pairojkul, C., & Okada, S. (2021). Mucin-producing hamster cholangiocarcinoma cell line, Ham-2, possesses the aggressive cancer phenotypes with liver and lung metastases. In vitro cellular & developmental biology. Animal, 57(8), 825-834. https://doi.org/10.1007/s11626-021-00608-z
Boonnate, Piyanard, et al. "Mucin-producing hamster cholangiocarcinoma cell line, Ham-2, possesses the aggressive cancer phenotypes with liver and lung metastases." In vitro cellular & developmental biology. Animal vol. 57,8 (2021): 825-834. doi: https://doi.org/10.1007/s11626-021-00608-z
Boonnate P, Vaeteewoottacharn K, Kariya R, Fujikawa S, Boonmars T, Pinlaor S, Pairojkul C, Okada S. Mucin-producing hamster cholangiocarcinoma cell line, Ham-2, possesses the aggressive cancer phenotypes with liver and lung metastases. In Vitro Cell Dev Biol Anim. 2021 Sep;57(8):825-834. doi: 10.1007/s11626-021-00608-z. Epub 2021 Sep 21. PMID: 34549357.
Copy Download .nbib Format: NLM
Patterns of Recurrence after Resection of Mass-Forming Type Intrahepatic Cholangiocarcinomas.

Asian Pacific journal of cancer prevention : APJCP

Luvira V, Eurboonyanun Ch, Bhudhisawasdi V, Pugkhem A, Pairojkul Ch, Luvira V, Sathitkarnmanee E, Somsap K, Kamsa-ard S.
PMID: 27893205
Asian Pac J Cancer Prev. 2016 Oct 01;17(10):4735-4739. doi: 10.22034/apjcp.2016.17.10.4735.

Background: Intrahepatic cholangiocarcinoma (IHCCA) is an aggressive tumor for which surgical resection is a mainstay of treatment. However, recurrence after resection is common associated with a poor prognosis. Studies regarding recurrence of mass-forming IHCCA are rare; therefore, we investigated...

Cite
Luvira V, Eurboonyanun Ch, Bhudhisawasdi V, et al. Patterns of Recurrence after Resection of Mass-Forming Type Intrahepatic Cholangiocarcinomas. Asian Pac J Cancer Prev. 2016;17(10):4735-4739doi: 10.22034/apjcp.2016.17.10.4735.
Luvira, V., Eurboonyanun, C. h., Bhudhisawasdi, V., Pugkhem, A., Pairojkul, C. h., Luvira, V., Sathitkarnmanee, E., Somsap, K., & Kamsa-ard, S. (2016). Patterns of Recurrence after Resection of Mass-Forming Type Intrahepatic Cholangiocarcinomas. Asian Pacific journal of cancer prevention : APJCP, 17(10), 4735-4739. https://doi.org/10.22034/apjcp.2016.17.10.4735
Luvira, Vor, et al. "Patterns of Recurrence after Resection of Mass-Forming Type Intrahepatic Cholangiocarcinomas." Asian Pacific journal of cancer prevention : APJCP vol. 17,10 (2016): 4735-4739. doi: https://doi.org/10.22034/apjcp.2016.17.10.4735
Luvira V, Eurboonyanun Ch, Bhudhisawasdi V, Pugkhem A, Pairojkul Ch, Luvira V, Sathitkarnmanee E, Somsap K, Kamsa-ard S. Patterns of Recurrence after Resection of Mass-Forming Type Intrahepatic Cholangiocarcinomas. Asian Pac J Cancer Prev. 2016 Oct 01;17(10):4735-4739. doi: 10.22034/apjcp.2016.17.10.4735. PMID: 27893205; PMCID: PMC5454625.
Copy Download .nbib Format: NLM
Morphological Classification of Intraductal Papillary Neoplasm of the Bile Duct with Survival Correlation.

Asian Pacific journal of cancer prevention : APJCP

Luvira V, Somsap K, Pugkhem A, Eurboonyanun Ch, Luvira V, Bhudhisawasdi V, Pairojkul Ch, Kamsa Ard S.
PMID: 28240521
Asian Pac J Cancer Prev. 2017 Jan 01;18(1):207-213. doi: 10.22034/APJCP.2017.18.1.207.

Background: Intraductal papillary neoplasm of the bile duct (IPNB) is a specific entity for which there has been no classification that correlates clinical presentation with patient survival. We, therefore, propose a new classification based on radio-pathological appearance correlated with...

Cite
Luvira V, Somsap K, Pugkhem A, et al. Morphological Classification of Intraductal Papillary Neoplasm of the Bile Duct with Survival Correlation. Asian Pac J Cancer Prev. 2017;18(1):207-213doi: 10.22034/APJCP.2017.18.1.207.
Luvira, V., Somsap, K., Pugkhem, A., Eurboonyanun, C. h., Luvira, V., Bhudhisawasdi, V., Pairojkul, C. h., & Kamsa Ard, S. (2017). Morphological Classification of Intraductal Papillary Neoplasm of the Bile Duct with Survival Correlation. Asian Pacific journal of cancer prevention : APJCP, 18(1), 207-213. https://doi.org/10.22034/APJCP.2017.18.1.207
Luvira, Vor, et al. "Morphological Classification of Intraductal Papillary Neoplasm of the Bile Duct with Survival Correlation." Asian Pacific journal of cancer prevention : APJCP vol. 18,1 (2017): 207-213. doi: https://doi.org/10.22034/APJCP.2017.18.1.207
Luvira V, Somsap K, Pugkhem A, Eurboonyanun Ch, Luvira V, Bhudhisawasdi V, Pairojkul Ch, Kamsa Ard S. Morphological Classification of Intraductal Papillary Neoplasm of the Bile Duct with Survival Correlation. Asian Pac J Cancer Prev. 2017 Jan 01;18(1):207-213. doi: 10.22034/APJCP.2017.18.1.207. PMID: 28240521; PMCID: PMC5563102.
Copy Download .nbib Format: NLM
Retraction Note to: FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1-TYMS axis uncoupling in 5-FU resistance.

Cell death & disease

Intuyod K, Saavedra-García P, Zona S, Lai CF, Jiramongkol Y, Vaeteewoottacharn K, Pairojkul C, Yao S, Yong JS, Trakansuebkul S, Waraasawapati S, Luvira V, Wongkham S, Pinlaor S, Lam EW.
PMID: 34035223
Cell Death Dis. 2021 May 25;12(6):539. doi: 10.1038/s41419-021-03807-4.

No abstract available.

Cite
Intuyod K, Saavedra-García P, Zona S, et al. Retraction Note to: FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1-TYMS axis uncoupling in 5-FU resistance. Cell Death Dis. 2021;12(6):539doi: 10.1038/s41419-021-03807-4.
Intuyod, K., Saavedra-García, P., Zona, S., Lai, C. F., Jiramongkol, Y., Vaeteewoottacharn, K., Pairojkul, C., Yao, S., Yong, J. S., Trakansuebkul, S., Waraasawapati, S., Luvira, V., Wongkham, S., Pinlaor, S., & Lam, E. W. (2021). Retraction Note to: FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1-TYMS axis uncoupling in 5-FU resistance. Cell death & disease, 12(6), 539. https://doi.org/10.1038/s41419-021-03807-4
Intuyod, Kitti, et al. "Retraction Note to: FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1-TYMS axis uncoupling in 5-FU resistance." Cell death & disease vol. 12,6 (2021): 539. doi: https://doi.org/10.1038/s41419-021-03807-4
Intuyod K, Saavedra-García P, Zona S, Lai CF, Jiramongkol Y, Vaeteewoottacharn K, Pairojkul C, Yao S, Yong JS, Trakansuebkul S, Waraasawapati S, Luvira V, Wongkham S, Pinlaor S, Lam EW. Retraction Note to: FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1-TYMS axis uncoupling in 5-FU resistance. Cell Death Dis. 2021 May 25;12(6):539. doi: 10.1038/s41419-021-03807-4. PMID: 34035223; PMCID: PMC8149627.
Copy Download .nbib Format: NLM
Cholangiocarcinoma Trends, Incidence, and Relative Survival in Khon Kaen, Thailand From 1989 Through 2013: A Population-Based Cancer Registry Study [J Epidemiol 29 (5) (2019) 197-204].

Journal of epidemiology

Kamsa-Ard S, Luvira V, Suwanrungruang K, Kamsa-Ard S, Luvira V, Santong C, Srisuk T, Pugkhem A, Bhudhisawasdi V, Pairojkul C.
PMID: 32023568
J Epidemiol. 2020;30(2):108-109. doi: 10.2188/jea.JE20190251.

No abstract available.

Cite
Kamsa-Ard S, Luvira V, Suwanrungruang K, et al. Cholangiocarcinoma Trends, Incidence, and Relative Survival in Khon Kaen, Thailand From 1989 Through 2013: A Population-Based Cancer Registry Study [J Epidemiol 29 (5) (2019) 197-204]. J Epidemiol. 2020;30(2):108-109doi: 10.2188/jea.JE20190251.
Kamsa-Ard, S., Luvira, V., Suwanrungruang, K., Kamsa-Ard, S., Luvira, V., Santong, C., Srisuk, T., Pugkhem, A., Bhudhisawasdi, V., & Pairojkul, C. (2020). Cholangiocarcinoma Trends, Incidence, and Relative Survival in Khon Kaen, Thailand From 1989 Through 2013: A Population-Based Cancer Registry Study [J Epidemiol 29 (5) (2019) 197-204]. Journal of epidemiology, 30(2), 108-109. https://doi.org/10.2188/jea.JE20190251
Kamsa-Ard, Supot, et al. "Cholangiocarcinoma Trends, Incidence, and Relative Survival in Khon Kaen, Thailand From 1989 Through 2013: A Population-Based Cancer Registry Study [J Epidemiol 29 (5) (2019) 197-204]." Journal of epidemiology vol. 30,2 (2020): 108-109. doi: https://doi.org/10.2188/jea.JE20190251
Kamsa-Ard S, Luvira V, Suwanrungruang K, Kamsa-Ard S, Luvira V, Santong C, Srisuk T, Pugkhem A, Bhudhisawasdi V, Pairojkul C. Cholangiocarcinoma Trends, Incidence, and Relative Survival in Khon Kaen, Thailand From 1989 Through 2013: A Population-Based Cancer Registry Study [J Epidemiol 29 (5) (2019) 197-204]. J Epidemiol. 2020;30(2):108-109. doi: 10.2188/jea.JE20190251. PMID: 32023568; PMCID: PMC6949186.
Copy Download .nbib Format: NLM
Anthocyanin complex exerts anti-cholangiocarcinoma activities and improves the efficacy of drug treatment in a gemcitabine-resistant cell line.

International journal of oncology

Intuyod K, Priprem A, Pairojkul C, Hahnvajanawong C, Vaeteewoottacharn K, Pinlaor P, Pinlaor S.
PMID: 29512768
Int J Oncol. 2018 May;52(5):1715-1726. doi: 10.3892/ijo.2018.4306. Epub 2018 Mar 07.

Cholangiocarcinoma (CCA) is a deleterious bile duct tumor with poor prognosis and is relatively resistant to chemotherapy. Therefore, alternative or supplementary agents with anticancer and chemosensitizing activities may be useful for the treatment of CCA. A novel anthocyanin complex...

Cite
Intuyod K, Priprem A, Pairojkul C, et al. Anthocyanin complex exerts anti-cholangiocarcinoma activities and improves the efficacy of drug treatment in a gemcitabine-resistant cell line. Int J Oncol. 2018;52(5):1715-1726doi: 10.3892/ijo.2018.4306.
Intuyod, K., Priprem, A., Pairojkul, C., Hahnvajanawong, C., Vaeteewoottacharn, K., Pinlaor, P., & Pinlaor, S. (2018). Anthocyanin complex exerts anti-cholangiocarcinoma activities and improves the efficacy of drug treatment in a gemcitabine-resistant cell line. International journal of oncology, 52(5), 1715-1726. https://doi.org/10.3892/ijo.2018.4306
Intuyod, Kitti, et al. "Anthocyanin complex exerts anti-cholangiocarcinoma activities and improves the efficacy of drug treatment in a gemcitabine-resistant cell line." International journal of oncology vol. 52,5 (2018): 1715-1726. doi: https://doi.org/10.3892/ijo.2018.4306
Intuyod K, Priprem A, Pairojkul C, Hahnvajanawong C, Vaeteewoottacharn K, Pinlaor P, Pinlaor S. Anthocyanin complex exerts anti-cholangiocarcinoma activities and improves the efficacy of drug treatment in a gemcitabine-resistant cell line. Int J Oncol. 2018 May;52(5):1715-1726. doi: 10.3892/ijo.2018.4306. Epub 2018 Mar 07. PMID: 29512768.
Copy Download .nbib Format: NLM
Adaptor protein XB130 regulates the aggressiveness of cholangiocarcinoma.

PloS one

Poosekeaw P, Pairojkul C, Sripa B, Sa Ngiamwibool P, Iamsaard S, Sakonsinsiri C, Thanan R, Ungarreevittaya P.
PMID: 34780466
PLoS One. 2021 Nov 15;16(11):e0259075. doi: 10.1371/journal.pone.0259075. eCollection 2021.

Cholangiocarcinoma (CCA) is a group of heterogenous malignancies arising from bile duct epithelium with distinct pathological features. Adaptor proteins have implicated in cell proliferation, migration, and invasion of different cancer cells. The objective of this study was to assess...

Cite
Poosekeaw P, Pairojkul C, Sripa B, et al. Adaptor protein XB130 regulates the aggressiveness of cholangiocarcinoma. PLoS One. 2021;16(11):e0259075doi: 10.1371/journal.pone.0259075.
Poosekeaw, P., Pairojkul, C., Sripa, B., Sa Ngiamwibool, P., Iamsaard, S., Sakonsinsiri, C., Thanan, R., & Ungarreevittaya, P. (2021). Adaptor protein XB130 regulates the aggressiveness of cholangiocarcinoma. PloS one, 16(11), e0259075. https://doi.org/10.1371/journal.pone.0259075
Poosekeaw, Pirawan, et al. "Adaptor protein XB130 regulates the aggressiveness of cholangiocarcinoma." PloS one vol. 16,11 (2021): e0259075. doi: https://doi.org/10.1371/journal.pone.0259075
Poosekeaw P, Pairojkul C, Sripa B, Sa Ngiamwibool P, Iamsaard S, Sakonsinsiri C, Thanan R, Ungarreevittaya P. Adaptor protein XB130 regulates the aggressiveness of cholangiocarcinoma. PLoS One. 2021 Nov 15;16(11):e0259075. doi: 10.1371/journal.pone.0259075. eCollection 2021. PMID: 34780466; PMCID: PMC8592414.
Copy Download .nbib Format: NLM
Curcumin-loaded nanocomplexes: Acute and chronic toxicity studies in mice and hamsters.

Toxicology reports

Jantawong C, Priprem A, Intuyod K, Pairojkul C, Pinlaor P, Waraasawapati S, Mongkon I, Chamgramol Y, Pinlaor S.
PMID: 34277359
Toxicol Rep. 2021 Jun 30;8:1346-1357. doi: 10.1016/j.toxrep.2021.06.021. eCollection 2021.

We recently developed a modified solid dispersion of curcumin-loaded nanocomplexes (CNCs) in gums which promoted the prolonged and sustained release of curcumin. However, its safety assessment has not yet been investigated. Here, acute and chronic toxicities of CNCs were...

Cite
Jantawong C, Priprem A, Intuyod K, et al. Curcumin-loaded nanocomplexes: Acute and chronic toxicity studies in mice and hamsters. Toxicol Rep. 2021;8:1346-1357doi: 10.1016/j.toxrep.2021.06.021.
Jantawong, C., Priprem, A., Intuyod, K., Pairojkul, C., Pinlaor, P., Waraasawapati, S., Mongkon, I., Chamgramol, Y., & Pinlaor, S. (2021). Curcumin-loaded nanocomplexes: Acute and chronic toxicity studies in mice and hamsters. Toxicology reports, 81346-1357. https://doi.org/10.1016/j.toxrep.2021.06.021
Jantawong, Chanakan, et al. "Curcumin-loaded nanocomplexes: Acute and chronic toxicity studies in mice and hamsters." Toxicology reports vol. 8 (2021): 1346-1357. doi: https://doi.org/10.1016/j.toxrep.2021.06.021
Jantawong C, Priprem A, Intuyod K, Pairojkul C, Pinlaor P, Waraasawapati S, Mongkon I, Chamgramol Y, Pinlaor S. Curcumin-loaded nanocomplexes: Acute and chronic toxicity studies in mice and hamsters. Toxicol Rep. 2021 Jun 30;8:1346-1357. doi: 10.1016/j.toxrep.2021.06.021. eCollection 2021. PMID: 34277359; PMCID: PMC8267493.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 24 entries